Review Article

Indoor air pollution and behavioral factors affecting to COVID-19 transition

Mojtaba Ehsanifar*, Mehravar Rafati and Zeinab Yavari

Published: 26 March, 2022 | Volume 3 - Issue 1 | Pages: 016-020

Environmental and behavioral factors are very important for exposure to airborne SARS-CoV-2. Indoor environments are related to infection events, including super-spreader events and outbreaks. Indoor, poorly ventilated, and crowded areas, such as restaurants, cinemas, and bars can be effective in the accumulation of aerosols full of viruses, especially if people are in conversations and stay there for a long time period. At longer distances (more than 1.5 meters), small aerosols that can stay in the air for a longer period of time are dominant. The super-spreader events in which people have been infected at a distance away show that this remote transmission occurs. The exposure risk to longer intervals is likely to be more in domestic environments and indoor spaces that lack sufficient ventilation. Layer interventions are of fundamental importance. Therefore, it is important to take preventive measures as much as possible and follow them as carefully as possible, because no intervention alone will be effective in eliminating the risk. These include spacing, lining, hand hygiene, filtration, and ventilation.

Read Full Article HTML DOI: 10.29328/journal.jcmhs.1001015 Cite this Article Read Full Article PDF


Indoor environment; COVID-19 transition; Airborne SARS-CoV-2; Behavioral factors; Indoor Air pollution


  1. Dong Y, Mo X, Hu Y, Qi X, Jiang F, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020; 145: e20200702.PubMed: https://pubmed.ncbi.nlm.nih.gov/32179660/
  2. Guerra, F.M, Bolotin S, Lim G, Heffernan J, Deeks SL, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis. 2017; 17: e420-e428. PubMed: https://pubmed.ncbi.nlm.nih.gov/28757186/
  3. Hamner L, Dubbel P, Capron I, Ross A, Jordan A, et al. High SARS-CoV-2 attack rate following exposure at a choir practice—Skagit County, Washington, March 2020. Morbidity and Mortality Weekly Report. 2020; 69: 6006-610.
  4. Ehsanifar M. Airborne aerosols particles and COVID-19 transition. Environ Res. 2021; 200: 111752. PubMed: https://pubmed.ncbi.nlm.nih.gov/34302822/
  5. Fisher KA, Tenforde MW, Feldstein LR, Lindsell CJ, Shapiro NI, et al. Community and close contact exposures associated with COVID-19 among symptomatic adults ≥ 18 years in 11 outpatient health care facilities—United States, July 2020. Morbidity and Mortality Weekly Report. 2020; 69: 1258-1264. PubMed: https://pubmed.ncbi.nlm.nih.gov/32915165/
  6. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020; 395: 1907-1918. PubMed: https://pubmed.ncbi.nlm.nih.gov/32473681/
  7. Ehsanifar M, Rafati M, Wang J. Neurological complications related to COVID-19 infections following exposure to airborne aerosol particles. Clin Res Clin Trials. 2022; 5.
  8. Inglesby TV. Public health measures and the reproduction number of SARS-CoV-2. JAMA. 2020; 323: 2186-2187. PubMed: https://pubmed.ncbi.nlm.nih.gov/32356869/
  9. Imai N. Report 3: Transmissibility of 2019-nCoV, WHO Collaborating Centre for Infectious Disease Modelling. MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, UK, 2020.
  10. Alford RH, Kasel JA, Gerone PJ, Knight V. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med. 1966; 122: 800-804. PubMed: https://pubmed.ncbi.nlm.nih.gov/5918954/
  11. Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, et al. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A/H1N1 virus healthy human challenge model. M Bio. 2016; 7: e00417-00416. PubMed: https://pubmed.ncbi.nlm.nih.gov/27094330/
  12. Lakdawala SS, Menachery VD. The search for a COVID-19 animal model. Science. 2020; 368: 942-943. PubMed: https://pubmed.ncbi.nlm.nih.gov/32467379/
  13. Halfmann PJ, Hatta M, Chiba S, Maemura T, Shufang Fan et al. Transmission of SARS-CoV-2 in domestic cats. New Engl J Med. 2020; 383: 592-594. PubMed: https://pubmed.ncbi.nlm.nih.gov/32402157/
  14. Richard M, Kok A, de Meulder D, Bestebroer TM, Lamers MM, Cet al. SARS-CoV-2 is transmitted via contact and via the air between ferrets. Nature Commun. 2020; 11: 1-6. PubMed: https://pubmed.ncbi.nlm.nih.gov/32641684/
  15. Ehsanifar M, Yavari Z, Motaghedifar MR, Rezaei M. Risk of activation of human viruses lurking in ambient following COVID-19 prevention supplies excessive use. J Community Med Health Solut. 2022; 3: 011-015. PubMed: https://www.heighpubs.org/jcmhs/jcmhs-aid1014.php
  16. Yang YExuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. MedRxiv. 2020.
  17. Sia SF. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020; 583: 834-838.
  18. Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, et al. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine. 2017; 35: 1586-1589. PubMed: https://pubmed.ncbi.nlm.nih.gov/28237499/
  19. Gralinski LE, Baric RS. Molecular pathology of emerging coronavirus infections. J Pathol. 2015; 235: 185-195. PubMed: https://pubmed.ncbi.nlm.nih.gov/25270030/
  20. Xu Z, Shi L, Wang Y, Zhang J, Huang L, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8: 420-422. PubMed: https://pubmed.ncbi.nlm.nih.gov/32085846/
  21. Zheng S, Fan J, Yu F, Feng B, Lou B, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020; 369:PubMed: https://pubmed.ncbi.nlm.nih.gov/32317267/
  22. Zhu S, Jenkins S, Addo K, Heidarinejad M, Romo SA, et al. Ventilation and laboratory confirmed acute respiratory infection (ARI) rates in college residence halls in College Park, Maryland. Environ Int. 2020; 137: 105537. PubMed: https://pubmed.ncbi.nlm.nih.gov/32028176/
  23. Wargocki P, Sundell J, Bischof W, Brundrett G, Fanger PO, et al. Ventilation and health in non-industrial indoor environments: report from a European multidisciplinary scientific consensus meeting (EUROVEN). Indoor Air. 2002; 12: 113-128. PubMed: https://pubmed.ncbi.nlm.nih.gov/12216467/
  24. Li Y, Qian H, Hang J, Chen X, Hong L, et al. Evidence for probable aerosol transmission of SARS-CoV-2 in a poorly ventilated restaurant. MedRxiv. 2020.
  25. Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, et al. Correlation between universal BCG vaccination policy and reduced mortality for COVID-19. MedRxiv. 2020.
  26. Liu L, Li Y, Nielsen PV, Wei J, Jensen RL. Short‐range airborne transmission of expiratory droplets between two people. Indoor Air. 2017; 27: 452-462. PubMed: https://pubmed.ncbi.nlm.nih.gov/27287598/
  27. Ehsanifar M. Does Exposure to Air Pollution Fine Particles and COVID-19 Contribute to the Risk of Ischemic Stroke? Health. 2021; 2: 1020.
  28. Jarvis CI, Zandvoort KV, Gimma A, Prem K, CMMID COVID-19 working group, et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK. BMC Med. 2020; 18: 1-10. PubMed: https://pubmed.ncbi.nlm.nih.gov/32375776/
  29. Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020; 5: e279-e288. PubMed: https://pubmed.ncbi.nlm.nih.gov/32311320/
  30. Milton DK, Fabian MP, Cowling BJ, Grantham ML, McDevitt JJ, et al. Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks. PLoS Pathog. 2013; 9: e1003205. PubMed: https://pubmed.ncbi.nlm.nih.gov/23505369/
  31. Leung NH, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Med. 2020; 26: 676-680. PubMed: https://pubmed.ncbi.nlm.nih.gov/32371934/
  32. Xiao F, Sun J, Xu Y, Li F, Huang X, et al. Infectious SARS-CoV-2 in feces of patient with severe COVID-19. Emerg Infect Dis. 2020; 26: 1920. PubMed: https://pubmed.ncbi.nlm.nih.gov/32421494/


Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?